AR032049A1 - Una composicion farmaceutica solida termoformable para la liberacion controlada de trimetazidina - Google Patents

Una composicion farmaceutica solida termoformable para la liberacion controlada de trimetazidina

Info

Publication number
AR032049A1
AR032049A1 ARP010106029A ARP010106029A AR032049A1 AR 032049 A1 AR032049 A1 AR 032049A1 AR P010106029 A ARP010106029 A AR P010106029A AR P010106029 A ARP010106029 A AR P010106029A AR 032049 A1 AR032049 A1 AR 032049A1
Authority
AR
Argentina
Prior art keywords
trimetazidine
pharmaceutical composition
controlled release
solid pharmaceutical
thermoformable
Prior art date
Application number
ARP010106029A
Other languages
English (en)
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR032049A1 publication Critical patent/AR032049A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una nueva composicion farmacéutica solida de liberacion controlada obtenida por termoformado, en caliente, de una mezcla basada en polímeros pertenecientes a la familia de polimetacrilato y trimetazidina o una de sus sales farmacéuticamente aceptables.
ARP010106029A 2000-12-26 2001-12-26 Una composicion farmaceutica solida termoformable para la liberacion controlada de trimetazidina AR032049A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0017014A FR2818549B1 (fr) 2000-12-26 2000-12-26 Composition pharmaceutique solide thermoformable pour la liberation controlee de trimetazidine

Publications (1)

Publication Number Publication Date
AR032049A1 true AR032049A1 (es) 2003-10-22

Family

ID=8858189

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP010106026A AR031970A1 (es) 2000-12-26 2001-12-26 Composicion farmaceutica solida termoformable para la liberacion controlada de ivabradina
ARP010106029A AR032049A1 (es) 2000-12-26 2001-12-26 Una composicion farmaceutica solida termoformable para la liberacion controlada de trimetazidina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP010106026A AR031970A1 (es) 2000-12-26 2001-12-26 Composicion farmaceutica solida termoformable para la liberacion controlada de ivabradina

Country Status (3)

Country Link
AR (2) AR031970A1 (es)
FR (1) FR2818549B1 (es)
WO (1) WO2002051417A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885807B1 (fr) * 2005-05-18 2008-05-16 Mg Pharma Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation
EP2187874A2 (en) * 2007-08-08 2010-05-26 Usv Limited Sustained release compositions of trimetazidine and process for preparation thereof
EP2200591A2 (en) * 2007-09-11 2010-06-30 Ranbaxy Laboratories Limited Controlled release pharmaceutical dosage forms of trimetazidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490963B1 (fr) * 1980-09-30 1986-04-18 Science Union & Cie Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine
JPH0625055B2 (ja) * 1985-03-18 1994-04-06 日本ケミフア株式会社 持続性錠剤
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
FR2717687B1 (fr) * 1994-03-24 1996-06-14 Adir Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale.
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates

Also Published As

Publication number Publication date
AR031970A1 (es) 2003-10-08
FR2818549B1 (fr) 2003-02-07
WO2002051417A1 (fr) 2002-07-04
FR2818549A1 (fr) 2002-06-28

Similar Documents

Publication Publication Date Title
CY1106390T1 (el) Στepεα θepμοδιαμορφωσιμη φαρμακευτικη συνθεση για την ελεγχομενη απελευθερωση της ιβαβραδινης
PA8518801A1 (es) Derivados de 2-aminocarbonil-9h-purina
EA200000584A2 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
AR031151A1 (es) Articulo absorbente
SV2003000633A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
EA200501901A1 (ru) Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путём
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
AR032049A1 (es) Una composicion farmaceutica solida termoformable para la liberacion controlada de trimetazidina
CR7648A (es) Microcapsulas para la liberacion retardada y controlada del perindropil
AR031972A1 (es) Composicion farmaceutica solida termoformable para la liberacion controlada de perindopril
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
AR028338A1 (es) Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
BR0314838A (pt) Sistema de liberação controlada, e, processo para preparar comprimidos de liberação controlada de temozolomida
HN1999000043A (es) Procedimiento para alquilar sulfonamidas impedidas estericamente.
HN2000000057A (es) Derivados de i - trifluorometil-4-hidroxi-7-piperidinil- aminometilcromano.
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
AR027537A1 (es) Un nuevo procedimiento para la preparacion de isoindolina
NO20052480D0 (no) Utvidede farmasoytiske sammensetninger med kontrollert frigjoring omfattende ladede polymerer.
GT199800008A (es) Procedimiento para la preparacion de un derivado de tetrahidropiridina.
AR044379A1 (es) Uso de jabones para aumentar la liberacion de compuestos con actividad farmaceutica desde formas de dosificacion farmaceutica
DOP2001000182A (es) 2-aminocarbonil-9h-derivados de purina
BRPI0414423A (pt) inibidores de pace4, suas composições farmacêuticas e respectivos usos
HN1999000128A (es) Nuevos usos farmaceuticos para inhibidores nos.
UY27824A1 (es) Nueva formulación para la administración parenteral de crobenetina.

Legal Events

Date Code Title Description
FB Suspension of granting procedure